These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17177882

  • 1. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM, Warnock M, Schmaier AH, Mosberg HI.
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K, Fatseas P, Melissari E, Vlahakos D, Roumelioti P, Mavromoustakos T, Mihailescu S, Paredes-Carbajal MC, Mascher D, Matsoukas J.
    J Med Chem; 2004 Jun 17; 47(13):3338-52. PubMed ID: 15189031
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K, Ramström S, Bjerke M, Lindahl TL.
    Thromb Haemost; 2007 Mar 17; 97(3):417-24. PubMed ID: 17334509
    [Abstract] [Full Text] [Related]

  • 7. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.
    Nieman MT, Pagan-Ramos E, Warnock M, Krijanovski Y, Hasan AA, Schmaier AH.
    FEBS Lett; 2005 Jan 03; 579(1):25-9. PubMed ID: 15620686
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
    Day JR, Haskard DO, Taylor KM, Landis RC.
    Ann Thorac Surg; 2006 Feb 03; 81(2):619-24. PubMed ID: 16427862
    [Abstract] [Full Text] [Related]

  • 11. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA, Sobczyk-Kojiro K, Mosberg HI.
    Chem Biol Drug Des; 2010 Jan 03; 75(1):35-9. PubMed ID: 19954432
    [Abstract] [Full Text] [Related]

  • 12. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K, Ohnishi T, Miura N, Sameshima H, Koide T, Tanaka KA, Maruyama I.
    Thromb Res; 2014 Jan 03; 133(1):66-72. PubMed ID: 24268424
    [Abstract] [Full Text] [Related]

  • 13. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H, Sturgeon SA, Jackson SP, Hamilton JR.
    Thromb Haemost; 2012 Feb 03; 107(2):328-37. PubMed ID: 22187047
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R, Canseco Mdel S, Lopez-Martínez J, Cruz PA, Pérez-Campos E, Cruz MM, Alva FC, Majluf-Cruz A, Zenteno E, Ruiz-Argüelles A.
    Prep Biochem Biotechnol; 2007 Feb 03; 37(2):139-47. PubMed ID: 17454824
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.